# Zhongke Mige

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhongke-mige

- Industry: Healthcare
- Headquarters: Chengdu, China
- Website: www.labideas.cn
- Latest round: Angel (Aug 6, 2025)
- Investors on record: 1

## About

Founded in 2024, Zhongke Mige operates as a provider of specialized services in biomaterials and geological analysis. In August 2025, Zhongke Mige raised an Angel funding from new investor Chengdu Science City Venture Capital. Zhongke Mige specializes in providing advanced technical services and solutions in the fields of biomaterials and geological analysis. The company offers a range of comprehensive services, including FIB (Focused Ion Beam), TEM (Transmission Electron Microscopy), and SEM (Scanning Electron Microscopy) analyses, along with CT (Computed Tomography) analysis and sample preparation. Their services cater to various industries, including research institutions, environmental analysis, and materials science, delivering critical insights for scientific exploration and innovation. Their client base includes academic researchers, industrial laboratories, and governmental organizations across major cities in China, such as Beijing, Shenzhen, and Chengdu. The revenue model for Zhongke Mige is based on service contracts and project-based engagements, where clients utilize their specialized scientific analyses and technical services. Transactions typically occur on a B2B basis, with institutions and companies engaging the firm for tailored testing and analysis solutions. The company operates on a fee-for-service structure, with customers paying for each analysis or service rendered. Various pricing plans may be in place, including bulk service discounts for high-volume clients, and potential partnerships with academic institutions for joint research projects. Primary revenue-generating services include advanced microscopy and analytical services that cater to diverse industries requiring detailed material characterization and geological assessments.
The company plans to utilize this funding to enhance its service offerings and expand into new markets. Efforts will focus on developing new analytical products and entering additional geographical regions, specifically targeting urban centers in China and potentially expanding to international markets by the end of 2026.

## Funding rounds

- Angel, Aug 6, 2025 — Tianfu Science and Technology Venture Capital

## Investors

- Tianfu Science and Technology Venture Capital (https://capitalatlas.ai/funds/tianfu-science-and-technology-venture-capital) — Angel